Difference between revisions of "Cashen A, et al. Biol. Blood Marrow Transplant. (2008) cited as Ref 629 in DOI: 10.1038/s41392-020-0110-5 (Q9892)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Added link to [sliswiki]: Cashen A, et al. Biol. Blood Marrow Transplant. (2008) cited as Ref 629 in DOI: 10.1038/s41392-020-0110-5, #quickstatements; #temporary_batch_1589988087154)
(‎Created claim: Page(s) (P105): 1253-1261, #quickstatements; #temporary_batch_1590074839150)
 
(7 intermediate revisions by the same user not shown)
Property / First Author string
 +
Cashen A
Property / First Author string: Cashen A / rank
 +
Normal rank
Property / DOI Identifier
 +
Property / DOI Identifier: 10.1016/j.bbmt.2008.08.011 / rank
 +
Normal rank
Property / PubMed ID
 +
Property / PubMed ID: 18940680 / rank
 +
Normal rank
Property / Publication Date
 +
2008
Timestamp+2008-01-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 year
Before0
After0
Property / Publication Date: 2008 / rank
 +
Normal rank
Property / Published In Name String
 +
Biol. Blood Marrow Transplant.
Property / Published In Name String: Biol. Blood Marrow Transplant. / rank
 +
Normal rank
Property / Volume
 +
14
Property / Volume: 14 / rank
 +
Normal rank
Property / title
 +
A phase II study of plerixafor (AMD3100) plus G-CSF for autologous hematopoietic progenitor cell mobilization in patients with Hodgkin lymphoma (English)
Property / title: A phase II study of plerixafor (AMD3100) plus G-CSF for autologous hematopoietic progenitor cell mobilization in patients with Hodgkin lymphoma (English) / rank
 +
Normal rank
Property / Page(s)
 +
1253-1261
Property / Page(s): 1253-1261 / rank
 +
Normal rank

Latest revision as of 15:47, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Cashen A, et al. Biol. Blood Marrow Transplant. (2008) cited as Ref 629 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Cashen A
    0 references
    0 references
    2008
    0 references
    Biol. Blood Marrow Transplant.
    0 references
    14
    0 references
    A phase II study of plerixafor (AMD3100) plus G-CSF for autologous hematopoietic progenitor cell mobilization in patients with Hodgkin lymphoma (English)
    0 references
    1253-1261
    0 references